A Year Of Change: Looking Back At Francis’ First Year At Teva

Teva’s CEO, In Charge For A Year, Has Laid Clear Its More Innovative Ambitions

Teva logo outside company building
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products